Support for Platform Technologies to Rapidly Respond to Disease X.
CEPI (Coalition for Epidemic Preparedness Innovations) is a global partnership between public, private, philanthropic, and civil organisations to develop vaccines to stop future epidemics.
This current call builds on the original call for platform technologies launched in September 2017. Its aim is to advance development of vaccine and other immunoprophylactic platform technologies that enable a rapid response to protect at-risk populations against emerging infectious diseases, including ‘Disease X’.
CEPI plans to invest in platform technologies that can improve timelines from identification of a pathogen sequence to the development of a vaccine candidate or immunoprophylactic product. Platform technologies should enable rapid product development, rapid scale-up, and rapid induction of immunity or immunoprophylactic benefit for use in outbreaks. These can be novel platforms or existing (proven) platforms where improvements can be made in terms of increased speed, reduced costs, and manufacturing scale-up to respond to both known and unknown threat situations.
Applications are open worldwide to all types of non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and academic institutions.
Applicants must be legal entities, or consortia comprised of legal entities. At least one of the partners in the applicant organisation or consortia of partnering organisations should have experience in human vaccine development and have a track record of bringing vaccine candidates through to human clinical trials in the past 10 years.
To be eligible, the applicant must have at least preclinical immunogenicity data from one pathogen to support the platform.
The call comprises a two stage application process, with this initial call for Expressions of Interest.
These forms can be submitted at any time and will be reviewed on a rolling basis, up until the final deadline of 14 October 2020 (15:00 CET).
More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.